Adverse effects of prenatal glucocorticoid treatment in the preterm infant

Acta Biomedica de l'Ateneo Parmense

Volumn 68, Issue SUPPL. 1, 1997, Pages 35-38

  Rubaltelli, F F ^a   Chiti, G ^a   Dani, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Newborn; Respiratory distress syndrome

Indexed keywords

GLUCOCORTICOID;

ADRENAL DISEASE; ARTICLE; BRAIN HEMORRHAGE; CORTICOSTEROID THERAPY; DRUG MECHANISM; DUCTUS ARTERIOSUS OBLITERATION; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; LUNG DYSPLASIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN MORTALITY; NEWBORN SEPSIS; PREMATURE LABOR; PRENATAL PERIOD; RISK BENEFIT ANALYSIS;

ANIMALS; FEMALE; FETAL GROWTH RETARDATION; FETUS; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PREGNANCY; PRENATAL CARE; RISK FACTORS; SEPSIS;

EID: 0031421890     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. NATIONAL INSTITUTES OF HEALTH CONSENSUS DEVELOPMENT CONFERENCE. Statement on the effect of corticosteroids for fetal maturation on perinatal outcomes: February 28 to March 2. 1994, National Institutes of Health, Bethesda, Maryland, JAMA 1995; 273: 413-418.
2. BRONSTEIN JM, GOLDENBERG RL. Practice variation in the use of corticosteroids: a comparison of eight data sets. Am J Obstet Gynecol 1995; 173: 296-298.
3. ATKINSON MW, GOLDENBERG RL, GAUDIER FL et al. Maternal corticosteroid and tocolytic treatment and morbidity and mortality in very low birth weight infants. Am J Obstet Gynecol 1995; 173: 299-305.
4. TAEUSCH HW JR. Glucocorticoid prophylaxis for respiratory distress syndrome: a review of potential toxicity. J Pediatr 1975; 87: 617-623.
5. LIGGINS GC, HOWIE RN, A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515-525.
6. GAMSU HR, MULIINGER BM, DONNAI P, DASH CH. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants : report of a UK multicentre trial. Br J Obstet Gynaecol 1989; 96: 401-410.
7. COLLABORATIVE GROUP ON ANTENATAL STEROID THERAPY. Effect of antenatal steroid administration on prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981; 141: 276-287.
8. COLLABORATIVE GROUP ON ANTENATAL STEROID THERAPY. Effects of antenatal dexamethasone administration in the infant: long term follow-up. J Pediatr 1984; 104: 259-267.
9. SMOLDERS-DE- HAAS H, NEUVEL J. SCHMAND B, TREFFERS PE,KOPPE JG, HOEKS J. Physical development and medical hystory of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12- year follow-up. Pediatrics 1990; 86: 65-70.
10. JASKOLL T, CHOY HA, MELNIK M. The glucocorticoid-glucocorticoid receptor signal transduction pathway, transforming growth factor β, and embryonic mouse lung development in vivo. Pediatr Res 1995; 39: 749-759.
11. DURHAM PL, WOHLFORD-LENANE CL, SNYDER JM. Glucocorticoid regulation of surfactant-associated protein in rabbit fetal lung in vivo. Anat Rec 1993; 273: 365-377.
12. BOGGARAM V, SMITH ME, MENDELSON CR. Regulation of expression of the gene encoding the major surfactant protein (SP-a) in human fetal lung in vitro. Disparate effect of glucocorticoid on transcription and on mRna stability. J Biol Chem 1989; 264: 11421-11427.
13. 2. J Pediatr 1981; 98: 126-128.
14. WASSERSTRUM N,HUHTA JC, MARI G, DAWOOD S,WILLIS RN, NEAL NK. Betamethasone and the human fetal ductus arteriosus. Obstet Gynecol 1989; 74: 897-900.
15. AZANCOT-BENISTY A, BENIFLA JL, MATIAS A, DE CRÉPY A, MADELENAT P. Constriction of the fetal ductus arteriosus during prenatal betamethasone therapy. Obstet Gynecol 1995; 85: 874-876.
16. PEPE GJ, ALBRECHT ED. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995;16:608-648.
17. PARKER CR JR, ATKINSON MW, OWEN J, ANDREWS WW. Dynamics of the fetal adrenal,cholesterol,and apolipoprotein B responses to antenatal betarnethasone therapy. Am J Obstet Gynecol 1996; 174:562-565.
18. BALLARD PL, BALLARD RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995; 173: 254-262.
19. CROWLEY PA, CHALMERS I, KEIRSE MJ. The effects of corticosteroid administration before preterm delivery : an overwiev of the incidence from controlled trials. Br J Obstet Gynecol 1990; 97: 11-25.
20. GRANATI B, GRELLA PV, PETTENAZZO A, DI LENARDO L, RUBALTELLI FF. The prevention of respiratory distress syndrome in premature infants: efficacy of antenatal aminophylline treatment versus prenatal glucocorticoid administration. Ped Pharmacol 1984; 4: 21-24.
21. CROWLEY PA, MRCOG, FRCPI. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995; 173: 322-334
22. OHLSSON A. Treatment of preterm premature rupture of the membranes: a meta-analysis. Am J Obstet Gynecol 1989; 160: 890-906.
23. WRIGHT LL, HORBAR JD,GUNKEL H, et al. Evidence from multicenter networks on the current use and affectiveness of antenatal corticosteroids in low birth weight infants Am J Obstet Gynecol 1995; 173: 263-274.
24. WRIGHT LL, VERTER J, YOUNES N, et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: the NICHD Neonatal Research Network. Am J Obstet Gynecol 1995; 173: 269-274.
25. BAUER CR, MORRISON JC, POOLE KW, et al. A decreased incidence of necrotizing enterocoutis after prenatal glucocorticoid therapy. Pediatrics 1984; 73: 682-688.